HighTower Advisors LLC lessened its holdings in CVS Health Corporation (NYSE:CVS – Free Report) by 13.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 313,300 shares of the pharmacy operator’s stock after selling 46,879 shares during the period. HighTower Advisors LLC’s holdings in CVS Health were worth $26,847,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Kilter Group LLC bought a new position in CVS Health in the 2nd quarter worth about $27,000. Beaird Harris Wealth Management LLC raised its holdings in shares of CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in shares of CVS Health during the 2nd quarter valued at about $30,000. Timbuktu Capital Management LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at about $31,000. Finally, Dunhill Financial LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at about $32,000. Institutional investors own 80.66% of the company’s stock.
Analyst Ratings Changes
CVS has been the subject of several recent analyst reports. Evercore restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, November 4th. Argus raised their target price on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, August 19th. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, November 9th. Robert W. Baird set a $107.00 target price on shares of CVS Health in a research report on Thursday, August 6th. Finally, Piper Sandler set a $106.00 price target on shares of CVS Health in a research note on Friday, November 13th. Twenty-three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.33.
View Our Latest Stock Analysis on CVS Health
CVS Health Trading Up 1.0%
Shares of CVS stock opened at $80.83 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The business has a 50-day moving average price of $88.42 and a two-hundred day moving average price of $89.29. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The firm has a market cap of $103.42 billion, a P/E ratio of 9.41, a price-to-earnings-growth ratio of 0.77 and a beta of 0.58.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to analysts’ expectations of $104.72 billion. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.60 EPS. Equities analysts anticipate that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s payout ratio is presently 30.97%.
Insider Transactions at CVS Health
In other news, EVP Prem Shah bought 23,855 shares of the business’s stock in a transaction on Friday, November 6th. The stock was acquired at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.85% of the stock is currently owned by corporate insiders.
CVS Health News Roundup
These are some of the CVS news items that stood out recently:
- Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
- Neutral Sentiment: CVS also announced winners of a youth soccer contest, with grants for their nonprofit organizations. This is brand and community outreach rather than a material financial catalyst. Article: CVS Pharmacy names Home Team Heroes contest winners
- Negative Sentiment: Renewed momentum for “Medicare for All” was cited as a factor weighing on health-insurer stocks. The prospect of major changes to private insurance could create sector-wide uncertainty for CVS and its Aetna business. Article: Medicare For All momentum sinks health insurer stocks
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Featured Articles
- Five stocks we like better than CVS Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
